Sort
8,912 grants matching “sars cov 2”
The range of recoding and analysis of a 50 nt bypass to probe ribosomal function
$280,932John F. Atkins · University Of Utah · R01 · FY2008 · GM
The range of recoding and analysis of a 50 nt bypass to probe ribosomal function
$280,866John F. Atkins · University Of Utah · R01 · FY2010 · GM
CORE B: GENOMICS CORE
$280,751Rafi Ahmed · Emory University · U19 · FY2024 · AI
Development of an Airborne Pathogen Capture and Detection System
$280,674Lia A Stanciu · Purdue University · · FY2022 · ENG
Vascular, Cardiac, and Lung Alveolar Human Microphysiological Systems for SARS-CoV-2 Drug Screening
$280,600George A Truskey · Duke University · UH3 · FY2020 · TR
The range of recoding and analysis of a 50 nt bypass to probe ribosomal function
$280,394John F. Atkins · University Of Utah · R01 · FY2009 · GM
Targeted in vivo perturbation for dissecting tissue immune responses
$280,366Philip L De Jager · Columbia University Health Sciences · U19 · FY2023 · AI
Implementation of a qPCR-based assay for the quantification of SARS-CoV-2-specific T cells in immunocompromised patients
$280,223Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · UH2 · FY2023 · CA
Necroptosis in SARS-CoV-2 pathogenesis, evolution, and therapy
$280,000Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R21 · FY2022 · AI
Neutralization studies of SARS-CoV-2 with variant S proteins
$280,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2021 · AI
Development of Murine Model for SARS-CoV Pathogenesis
$279,892University Of Iowa · P01 · FY2005 · AI
Strep-CaDI: A fast, accurate, and sensitive point-of-care test for Group A Streptococcus
$279,557Zachary David Call · Burst Diagnostics Llc · R43 · FY2023 · AI
Molecular Pathways of Programmed Cell Death And Viral Cytopathicity
$279,307Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Integrated Network Analysis of RADx-UP Data to Increase COVID-19 Testing and Vaccination Among Persons Involved with Criminal Legal Systems (PCLS)
$279,230Aditya Subhash Khanna · Brown University · R21 · FY2023 · MD
RNA-based multi-antigen vaccine for SARS-CoV-2
$278,957Christian W. Mandl · Tiba Biotech, Llc · R43 · FY2021 · AI
UC Davis Environmental Health Sciences Core Center
$278,846Irva Hertz-Picciotto · University Of California At Davis · P30 · FY2021 · ES
DMS/NIGMS 2: Integrated Analysis of Fusion Protein Conformational Changes for Virus Entry
$278,687Jin Liu · Washington State University · R01 · FY2023 · GM
Novel animal models to study organ-specific SARS-CoV-2-induced pathology
$278,500Alexei V Tumanov · University Of Texas Hlth Science Center · R21 · FY2023 · AI
Channeling the voice of underserved communities on nutritional insufficiency and unaddressed needs on maternal infant health.
$278,494Marcia R Cruz Correa · University Of Puerto Rico Med Sciences · U54 · FY2021 · GM
Collaborative Research: DMS/NIGMS 1: Identifiability investigation of Multi-scale Models of Infectious Diseases
$278,462Stanca M. Ciupe · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · GM
Project 3: SARS CoV-2 Lung Organoid Interactions in Replication and Pathogenesis
$278,458Ralph S Baric · Stanford University · U19 · FY2023 · AI
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
$278,287Jun Wang · University Of Arizona · R01 · FY2021 · AI
Persistence and Evolution of SARS-CoV-2
$278,238Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Multivalent protein-DNA nanostructures as synthetic blocking antibodies
$278,093Nicholas Stephanopoulos · Arizona State University-Tempe Campus · R01 · FY2025 · GM
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
$277,710David H Farrell · Gamma Therapeutics, Inc. · R41 · FY2023 · HL